These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32560578)

  • 1. 1-(1-Arylethylpiperidin-4-yl)thymine Analogs as Antimycobacterial TMPK Inhibitors.
    Jian Y; Hulpia F; D P Risseeuw M; Forbes HE; Caljon G; Munier-Lehmann H; I M Boshoff H; Van Calenbergh S
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32560578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-(Piperidin-3-yl)thymine amides as inhibitors of
    Jian Y; Risseeuw MDP; Froeyen M; Song L; Cappoen D; Cos P; Munier-Lehmann H; van Calenbergh S
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1730-1739. PubMed ID: 31822127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure activity relationships of cyanopyridone based anti-tuberculosis agents.
    Jian Y; Hulpia F; Risseeuw MDP; Forbes HE; Munier-Lehmann H; Caljon G; Boshoff HIM; Van Calenbergh S
    Eur J Med Chem; 2020 Sep; 201():112450. PubMed ID: 32623208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endeavors towards transformation of M. tuberculosis thymidylate kinase (MtbTMPK) inhibitors into potential antimycobacterial agents.
    Jian Y; Merceron R; De Munck S; Forbes HE; Hulpia F; Risseeuw MDP; Van Hecke K; Savvides SN; Munier-Lehmann H; Boshoff HIM; Van Calenbergh S
    Eur J Med Chem; 2020 Nov; 206():112659. PubMed ID: 32823003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elaboration of a proprietary thymidylate kinase inhibitor motif towards anti-tuberculosis agents.
    Song L; Risseeuw MDP; Froeyen M; Karalic I; Goeman J; Cappoen D; Van der Eycken J; Cos P; Munier-Lehmann H; Van Calenbergh S
    Bioorg Med Chem; 2016 Nov; 24(21):5172-5182. PubMed ID: 27614917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-aided optimization of non-nucleoside M. tuberculosis thymidylate kinase inhibitors.
    Song L; Merceron R; Hulpia F; Lucía A; Gracia B; Jian Y; Risseeuw MDP; Verstraelen T; Cos P; Aínsa JA; Boshoff HI; Munier-Lehmann H; Savvides SN; Van Calenbergh S
    Eur J Med Chem; 2021 Dec; 225():113784. PubMed ID: 34450493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug design and identification of potent leads against mycobacterium tuberculosis thymidine monophosphate kinase.
    Van Calenbergh S; Pochet S; Munier-Lehmann H
    Curr Top Med Chem; 2012; 12(7):694-705. PubMed ID: 22283813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new family of inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.
    Gasse C; Huteau V; Douguet D; Munier-Lehmann H; Pochet S
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1057-61. PubMed ID: 18058536
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-Arylaminouracil Derivatives: New Inhibitors of Mycobacterium tuberculosis.
    Matyugina E; Novikov M; Babkov D; Ozerov A; Chernousova L; Andreevskaya S; Smirnova T; Karpenko I; Chizhov A; Murthu P; Lutz S; Kochetkov S; Seley-Radtke KL; Khandazhinskaya AL
    Chem Biol Drug Des; 2015 Dec; 86(6):1387-96. PubMed ID: 26061192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure Guided Lead Generation toward Nonchiral M. tuberculosis Thymidylate Kinase Inhibitors.
    Song L; Merceron R; Gracia B; Quintana AL; Risseeuw MDP; Hulpia F; Cos P; Aínsa JA; Munier-Lehmann H; Savvides SN; Van Calenbergh S
    J Med Chem; 2018 Apr; 61(7):2753-2775. PubMed ID: 29510037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidine and thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
    Vanheusden V; Van Rompaey P; Munier-Lehmann H; Pochet S; Herdewijn P; Van Calenbergh S
    Bioorg Med Chem Lett; 2003 Sep; 13(18):3045-8. PubMed ID: 12941330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of C-5 modified 2'-deoxyuridine monophosphates as inhibitors of M. tuberculosis thymidylate synthase.
    Alexandrova LA; Chekhov VO; Shmalenyuk ER; Kochetkov SN; El-Asrar RA; Herdewijn P
    Bioorg Med Chem; 2015 Nov; 23(22):7131-7. PubMed ID: 26482569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against
    Venugopala KN; Tratrat C; Pillay M; Chandrashekharappa S; Al-Attraqchi OHA; Aldhubiab BE; Attimarad M; Alwassil OI; Nair AB; Sreeharsha N; Venugopala R; Morsy MA; Haroun M; Kumalo HM; Odhav B; Mlisana K
    Drug Des Devel Ther; 2020; 14():1027-1039. PubMed ID: 32214795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of 2-((2,3-dihydrobenzo[b][1,4]dioxin-6-yl)amino)-N-phenylpropanamides as a novel class of potent DprE1 inhibitors.
    Whitehurst BC; Young RJ; Burley GA; Cacho M; Torres P; Vela-Gonzalez Del Peral L
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127192. PubMed ID: 32312582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First triclosan-based macrocyclic inhibitors of InhA enzyme.
    Rodriguez F; Saffon N; Sammartino JC; Degiacomi G; Pasca MR; Lherbet C
    Bioorg Chem; 2020 Jan; 95():103498. PubMed ID: 31855823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3'-C-branched-chain-substituted nucleosides and nucleotides as potent inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.
    Vanheusden V; Munier-Lehmann H; Froeyen M; Dugué L; Heyerick A; De Keukeleire D; Pochet S; Busson R; Herdewijn P; Van Calenbergh S
    J Med Chem; 2003 Aug; 46(18):3811-21. PubMed ID: 12930144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leads.
    Wang X; Zhao W; Wang B; Ding W; Guo H; Zhao H; Meng J; Liu S; Lu Y; Liu Y; Zhang D
    Bioorg Chem; 2021 Sep; 114():105110. PubMed ID: 34175719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring acyclic nucleoside analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
    Familiar O; Munier-Lehmann H; Negri A; Gago F; Douguet D; Rigouts L; Hernández AI; Camarasa MJ; Pérez-Pérez MJ
    ChemMedChem; 2008 Jul; 3(7):1083-93. PubMed ID: 18418833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
    Matviiuk T; Rodriguez F; Saffon N; Mallet-Ladeira S; Gorichko M; de Jesus Lopes Ribeiro AL; Pasca MR; Lherbet C; Voitenko Z; Baltas M
    Eur J Med Chem; 2013; 70():37-48. PubMed ID: 24140915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
    Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV
    Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.